As of 2026-06-10, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (7.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.72 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -515.5%.
The range of the Relative Valuation is (6.62) - (7.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 16.9x | 15.8x |
| Forward P/E multiples | 12.7x - 18.8x | 15.8x |
| Fair Price | (6.62) - (7.67) | (7.15) |
| Upside | -485.2% - -545.8% | -515.5% |
| Date | P/E |
| 2026-06-08 | -3.83 |
| 2026-06-05 | -3.59 |
| 2026-06-04 | -3.88 |
| 2026-06-03 | -4.10 |
| 2026-06-02 | -3.61 |
| 2026-06-01 | -3.66 |
| 2026-05-29 | -3.86 |
| 2026-05-28 | -3.86 |
| 2026-05-27 | -3.77 |
| 2026-05-26 | -3.92 |
| 2026-05-22 | -3.42 |
| 2026-05-21 | -3.50 |
| 2026-05-20 | -3.42 |
| 2026-05-19 | -3.39 |
| 2026-05-18 | -3.53 |
| 2026-05-15 | -3.70 |
| 2026-05-14 | -3.66 |
| 2026-05-13 | -3.75 |
| 2026-05-12 | -3.77 |
| 2026-05-11 | -3.88 |
| 2026-05-08 | -3.81 |
| 2026-05-07 | -3.81 |
| 2026-05-06 | -3.83 |
| 2026-05-05 | -3.79 |
| 2026-05-04 | -3.57 |
| 2026-05-01 | -3.50 |
| 2026-04-30 | -3.35 |
| 2026-04-29 | -3.31 |
| 2026-04-28 | -3.46 |
| 2026-04-27 | -3.48 |
| 2026-04-24 | -3.42 |
| 2026-04-23 | -3.53 |
| 2026-04-22 | -3.75 |
| 2026-04-21 | -3.70 |
| 2026-04-20 | -3.92 |
| 2026-04-17 | -3.97 |
| 2026-04-16 | -3.97 |
| 2026-04-15 | -4.03 |
| 2026-04-14 | -3.94 |
| 2026-04-13 | -3.97 |
| 2026-04-10 | -3.92 |
| 2026-04-09 | -3.50 |
| 2026-04-08 | -3.46 |
| 2026-04-07 | -3.35 |
| 2026-04-06 | -3.39 |
| 2026-04-02 | -3.66 |
| 2026-04-01 | -3.70 |
| 2026-03-31 | -3.72 |
| 2026-03-30 | -3.70 |
| 2026-03-27 | -3.90 |